Procaps Group S A Asset Turnover Ratio (PROCF), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Procaps Group S a   (PROCF)
 

Procaps Group S A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Procaps Group S A asset turnover ratio, the ability of Procaps Group S A 's assets to generate revenue in the fourth quarter 2023, increased sequentially to 0.92 in the fourth quarter (Dec 31 2023), PROCF's balance sheet remain strong.

Within sector 24 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from to 1174.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PROCF Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change -26.44 % 8.03 % 2.68 % 53.77 % 2.68 %
Y / Y Revenue Change 3.37 % - -2.1 % - -
Asset Turnover Ratio (TTM) 0.92 - 0.87 - 0.99
PROCF's Total Ranking # 1174 # # # #
Seq. Asset Change -53.57 % 58.45 % -36.85 % 58.36 % -31.82 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 25
Healthcare Sector # 104
Overall Market # 1174

Asset Turnover Ratio Statistics
High Average Low
0.9 0.9 0.9
(Dec 31 2023)  




PROCF Company Profile • Back to PROCF Efficiency Comparisons • Compare PROCF Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Jrsis Health Care Corp  3.84 $ 3.939  Millions$ 1.025  Millions
Lifemd Inc   3.58 $ 151.002  Millions$ 42.122  Millions
First Choice Healthcare Solutions Inc   3.40 $ 72.259  Millions$ 21.243  Millions
Lifevantage Corp  3.16 $ 210.317  Millions$ 66.483  Millions
Newgenivf Group Limited  3.12 $ 5.136  Millions$ 1.647  Millions
Interpace Biosciences Inc   2.70 $ 39.904  Millions$ 14.773  Millions
Escalon Medical Corp   2.47 $ 12.384  Millions$ 5.016  Millions
Patterson Companies Inc   2.27 $ 6,565.239  Millions$ 2,898.104  Millions
Healthcare Services Group Inc   2.21 $ 1,671.389  Millions$ 755.565  Millions
Euda Health Holdings Limited  2.17 $ 2.842  Millions$ 1.311  Millions
Hims and Hers Health Inc   2.15 $ 871.949  Millions$ 405.310  Millions
Rosecliff Acquisition Corp I  2.14 $ 18.056  Millions$ 8.435  Millions
Cano Health Inc   2.14 $ 3,137.757  Millions$ 1,469.342  Millions
Neuraxis Inc   2.06 $ 2.460  Millions$ 1.191  Millions
Agilon Health Inc   2.02 $ 4,316.363  Millions$ 2,135.533  Millions
Earth Science Tech Inc   1.98 $ 5.570  Millions$ 2.813  Millions
Bespoke Extracts Inc  1.88 $ 0.786  Millions$ 0.417  Millions
Integrated Biopharma Inc  1.87 $ 48.833  Millions$ 26.168  Millions
Nature s Sunshine Products inc   1.85 $ 445.127  Millions$ 240.106  Millions
Neptune Wellness Solutions Inc   1.83 $ 39.115  Millions$ 21.405  Millions
Sunlink Health Systems Inc   1.82 $ 40.052  Millions$ 22.052  Millions
Rockwell Medical inc   1.81 $ 82.927  Millions$ 45.822  Millions
Privia Health Group Inc   1.74 $ 1,657.737  Millions$ 951.287  Millions
Zeo Scientifix Inc   1.69 $ 4.642  Millions$ 2.751  Millions
Mimedx Group Inc   1.66 $ 320.687  Millions$ 193.151  Millions
Kewaunee Scientific Corporation  1.61 $ 198.397  Millions$ 122.932  Millions
Encision Inc   1.61 $ 6.867  Millions$ 4.256  Millions
Vycor Medical Inc   1.58 $ 1.422  Millions$ 0.898  Millions
Agile Therapeutics Inc  1.57 $ 18.615  Millions$ 11.853  Millions
Champions Oncology Inc   1.55 $ 49.224  Millions$ 31.706  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.